HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

FGF1 - a new weapon to control type 2 diabetes mellitus.

Abstract
A hypercaloric diet combined with a sedentary lifestyle is a major risk factor for the development of insulin resistance, type 2 diabetes mellitus (T2DM) and associated comorbidities. Standard treatment for T2DM begins with lifestyle modification, and includes oral medications and insulin therapy to compensate for progressive β-cell failure. However, current pharmaceutical options for T2DM are limited in that they do not maintain stable, durable glucose control without the need for treatment intensification. Furthermore, each medication is associated with adverse effects, which range from hypoglycaemia to weight gain or bone loss. Unexpectedly, fibroblast growth factor 1 (FGF1) and its low mitogenic variants have emerged as potentially safe candidates for restoring euglycaemia, without causing overt adverse effects. In particular, a single peripheral injection of FGF1 can lower glucose to normal levels within hours, without the risk of hypoglycaemia. Similarly, a single intracerebroventricular injection of FGF1 can induce long-lasting remission of the diabetic phenotype. This Review discusses potential mechanisms by which centrally administered FGF1 improves central glucose-sensing and peripheral glucose uptake in a sustained manner. Specifically, we explore the potential crosstalk between FGF1 and glucose-sensing neuronal circuits, hypothalamic neural stem cells and synaptic plasticity. Finally, we highlight therapeutic considerations of FGF1 and compare its metabolic actions with FGF15 (rodents), FGF19 (humans) and FGF21.
AuthorsEmanuel Gasser, Christopher P Moutos, Michael Downes, Ronald M Evans
JournalNature reviews. Endocrinology (Nat Rev Endocrinol) Vol. 13 Issue 10 Pg. 599-609 (Oct 2017) ISSN: 1759-5037 [Electronic] England
PMID28664920 (Publication Type: Journal Article, Review)
Chemical References
  • Blood Glucose
  • Insulin
  • Fibroblast Growth Factor 1
Topics
  • Animals
  • Blood Glucose (drug effects, metabolism)
  • Diabetes Mellitus, Type 2 (diagnosis, drug therapy, metabolism)
  • Disease Models, Animal
  • Female
  • Fibroblast Growth Factor 1 (administration & dosage, metabolism)
  • Follow-Up Studies
  • Humans
  • Insulin (metabolism)
  • Insulin Resistance
  • Male
  • Mice, Inbred C57BL
  • Random Allocation
  • Role
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: